IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FRANCESCHINI, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.127
EU - Europa 8.254
AS - Asia 3.469
SA - Sud America 26
AF - Africa 24
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 22.933
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.081
IT - Italia 3.968
CN - Cina 1.610
UA - Ucraina 1.441
DE - Germania 877
SG - Singapore 777
HK - Hong Kong 601
FI - Finlandia 449
IE - Irlanda 361
GB - Regno Unito 334
TR - Turchia 326
FR - Francia 271
PL - Polonia 137
SE - Svezia 101
RU - Federazione Russa 82
IN - India 68
BE - Belgio 43
CA - Canada 42
ES - Italia 25
EE - Estonia 23
NL - Olanda 19
RO - Romania 18
CZ - Repubblica Ceca 16
AU - Australia 15
BR - Brasile 14
EU - Europa 14
VN - Vietnam 14
CH - Svizzera 13
ID - Indonesia 12
HR - Croazia 11
MK - Macedonia 11
EG - Egitto 10
GR - Grecia 9
IR - Iran 9
JP - Giappone 9
LU - Lussemburgo 8
PK - Pakistan 7
SA - Arabia Saudita 7
SK - Slovacchia (Repubblica Slovacca) 6
AT - Austria 5
CI - Costa d'Avorio 5
IL - Israele 5
PH - Filippine 5
UG - Uganda 5
BG - Bulgaria 4
CL - Cile 4
LT - Lituania 4
RS - Serbia 4
AM - Armenia 3
JO - Giordania 3
LI - Liechtenstein 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
PE - Perù 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CY - Cipro 2
DK - Danimarca 2
IQ - Iraq 2
MX - Messico 2
PT - Portogallo 2
TH - Thailandia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MS - Montserrat 1
MY - Malesia 1
NO - Norvegia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 22.933
Salva come PNG Salva come JPEG
Città #
Fairfield 1.572
Woodbridge 1.143
Jacksonville 1.085
Ashburn 803
Houston 794
Cambridge 625
Singapore 615
Hong Kong 599
Seattle 588
Ann Arbor 587
Wilmington 563
Princeton 549
Chandler 477
Nanjing 350
Dublin 293
Helsinki 293
Istanbul 292
Beijing 286
Milan 285
New York 278
Brescia 179
Rome 175
Warsaw 130
Nanchang 121
San Diego 110
Des Moines 105
Hebei 105
Florence 100
Shenyang 99
Shanghai 84
Changsha 79
Tianjin 74
Jinan 67
Jiaxing 63
Verona 61
London 55
Trieste 54
Munich 53
Hangzhou 48
Turin 46
Bergamo 44
Dearborn 42
Los Angeles 42
San Francisco 42
Brussels 39
Lancaster 38
Genoa 35
Udine 34
Romola 33
Kunming 32
Ningbo 32
Padova 30
Bologna 28
Toronto 26
Lappeenranta 25
Genova 24
Pisa 24
Taizhou 23
Tallinn 23
Zhengzhou 23
Haikou 22
Lanzhou 22
Kocaeli 21
Syracuse 21
Boardman 20
Menlo Park 20
Torino 19
Nürnberg 18
Reggio Nell'emilia 18
Guangzhou 17
Mumbai 17
Redwood City 17
Modena 16
Norwalk 15
Orange 15
Rozzano 15
Washington 15
Brno 14
Dong Ket 14
Monmouth Junction 14
Naples 14
Palermo 14
Pune 14
Trento 14
Desio 13
San Mateo 13
Jakarta 12
Kilburn 12
Paris 12
Bari 11
Dallas 11
Ferrara 11
Pordenone 11
Rho 11
Split 11
Venice 11
Catania 10
Cosenza 10
Falkenstein 10
Melbourne 10
Totale 15.109
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.133
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.530
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 222
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 160
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 156
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 152
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 143
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 138
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 132
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 131
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 130
Antiphospholipid antibodies mediate autoimmunity against dying cells. 127
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 125
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 123
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 122
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 122
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 121
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 120
The clinico-serological spectrum of overlap myositis 119
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 119
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 118
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 118
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 117
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 115
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 115
Autoimmune polyendocrine Syndromes 114
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 114
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 113
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 112
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 111
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 109
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 109
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 108
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 107
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 107
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 106
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 106
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 106
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 106
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 105
Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: The positive experience of a national multicentre study 105
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 104
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 104
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 104
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 101
Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide 100
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 100
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 100
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 99
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 98
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 98
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 98
Incidence of antiperinuclear factor in patients with psoriatic arthritis. 97
Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. 97
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 97
Antiperinuclear factor in psoriatic arthropathy 95
Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference 95
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 94
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 92
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 92
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 92
Anti-Ro/SSA and La/SSB antibodies 92
Pathogenetic associations of maternal anti-Ro/SSA antibodies. 91
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 91
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 91
Myositis autoantibodies and clinical phenotypes 91
In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings. 91
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 90
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 90
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 90
Determination of antibodies to extractable nuclear antigens by commercial kits: a multicenter study 88
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 87
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 87
Switching from Intravenous to Subcutaneous Formulation of Abatacept: A Single-center Italian Experience on Efficacy and Safety 87
The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus 87
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 87
Update on Antiphospholipid Syndrome: Ten Topics in 2017 87
Cardiological features in idiopathic inflammatory myopathies. 86
Serologic profile and mortality rates of scleroderma renal crisis in Italy 86
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 86
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 85
Echocardiographic Evaluation of Asymptomatic Patients Affected by Rheumatoid Arthritis 84
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 84
Incidence of antiperinuclear factor in sera of patients with psoriatic arthritis 83
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 83
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 82
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 81
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 81
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 81
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 81
Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al 81
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 81
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 81
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience. 81
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 80
Retention of a bile acid analogue in the enterohepatic circulation (EHC) in primary biliary cirrhosis (PBC): comparison with normal controls and effect of bile acid treatment. 80
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 80
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 80
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 79
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 78
Totale 13.714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.367 0 0 0 0 285 510 414 538 384 748 166 322
2020/20214.009 94 438 162 444 242 467 156 446 466 472 395 227
2021/20223.010 185 401 140 176 164 200 201 234 193 296 272 548
2022/20232.266 341 38 51 99 194 564 47 229 384 56 139 124
2023/20242.853 150 84 228 246 134 458 134 138 667 94 107 413
2024/20251.754 117 156 125 731 625 0 0 0 0 0 0 0
Totale 23.414